FDA Releases Guidance for Institutional Review Boards on Reviewing Clinical Research Qualifications and Sites

Summary

The FDA has published a guidance document to help IRBs, clinical investigators, and sponsors ensure the protection of human subjects in clinical research by reviewing investigator qualifications, research site adequacy, and determining if an IND or IDE is needed.